Endectocides for malaria control

Trends in Parasitology

Volumn 27, Issue 10, 2011, Pages 423-428

  Foy, Brian D ^a   Kobylinski, Kevin C ^a   Silva, Ines Marques da ^a   Rasgon, Jason L ^b,c   Sylla, Massamba ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; IVERMECTIN;

ANOPHELES; DRUG EFFECT; MALARIA; MALARIA CONTROL; NONHUMAN; PARASITE TRANSMISSION; PARASITE VECTOR; REVIEW; VECTOR CONTROL;

ANIMALS; ANOPHELES; ANTHELMINTICS; DISEASE TRANSMISSION, INFECTIOUS; DISEASE VECTORS; DRUG RESISTANCE; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; MALARIA; MOSQUITO CONTROL; PLASMODIUM; SEASONS;

NEMATODA; VERTEBRATA;

EID: 80052919214     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.05.007     Document Type: Review

References (57)

1. Campbell W.C. Ivermectin and Abamectin 1989, Springer Verlag.
2. Cupp E.W., et al. Elimination of human onchocerciasis: History of progress and current feasibility using ivermectin (Mectizan®) monotherapy. Acta Trop. 2010, 10.1016/j.actatropica.2010.08.009.
3. Wilson M.L. Avermectins in arthropod vector management - prospects and pitfalls. Parasitol. Today 1993, 9:83-87.
4. Pampiglioni S., et al. Avermectins, MK-933 and MK-936, for mosquito control. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:797-799.
5. Gardner K., et al. Effects of ivermectin in canine blood on Anopheles quadrimaculatus, Aedes albopictus and Culex salinarius. J. Am. Mosq. Control Assoc. 1993, 9:400-402.
6. Tesh R.B., Guzman H. Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin. Am. J. Trop. Med. Hyg. 1990, 43:229-233.
7. Focks D.A., et al. Effects of ivermectin (MK-933) on the reproductive rate of Aedes aegypti (Diptera: Culicidae). J. Med. Entomol. 1991, 28:501-505.
8. Fritz M.L., et al. Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. Ann. Trop. Med. Parasitol. 2009, 103:539-547.
9. Kobylinski K.C., et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010, 116:119-126.
10. Cartel J.L., et al. Cumulative mortality rates in Aedes polynesiensis after feeding on polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo. Trop. Med. Parasitol. 1991, 42:343-345.
11. Foley D.H., et al. The potential of ivermectin to control the malaria vector Anopheles farauti. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:625-628.
12. Chaccour C., et al. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J. Infect. Dis. 2010, 202:113-116.
13. Bockarie M.J., et al. Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Med. Vet. Entomol. 1999, 13:120-123.
14. Sylla M., et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar. J. 2010, 9:365.
15. Kobylinski K.C., et al. Short report: Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. Am. J. Trop. Med. Hyg. 2011, 85:3-5.
16. World Health Organization Global Malaria Control and Elimination: Report of a Technical Review 2008, World Health Organization, p. 47.
17. Charlwood J.D., et al. Do bednets reduce malaria transmission by exophagic mosquitoes?. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:901-904.
18. Ferguson H.M., et al. Ecology: a prerequisite for malaria elimination and eradication. PLoS Med. 2010, 7:e1000303.
19. Lines J.D. Do agricultural insecticides select for insecticide resistance in mosquitoes? A look at the evidence. Parasitol. Today 1988, 4:S17-S20.
20. Strycharz J.P., et al. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J. Med. Entomol. 2008, 45:75-81.
21. Greenwood B.M. Control to elimination: implications for malaria research. Trends Parasitol. 2008, 24:449-454.
22. Burnham G., Mebrahtu T. The delivery of ivermectin (Mectizan). Trop. Med. Int. Health 2004, 9:A26-A44.
23. Goldman A.S., et al. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl. Trop. Dis. 2007, 1:e67.
24. Duke B.O., et al. Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am. J. Trop. Med. Hyg. 1990, 43:657-664.
25. Guzzo C.A., et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J. Clin. Pharmacol. 2002, 42:1122-1133.
26. Kamgno J., et al. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Am. J. Trop. Med. Hyg. 2009, 81:1056-1061.
27. Geary T.G., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
28. Gutman J., et al. Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths. Am. J. Trop. Med. Hyg. 2010, 83:534-541.
29. Brooker S., et al. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 2007, 77:88-98.
30. Midzi N., et al. Consequences of polyparasitism on anaemia among primary school children in Zimbabwe. Acta Trop. 2010, 115:103-111.
31. Yatich N.J., et al. The effect of malaria and intestinal helminth coinfection on birth outcomes in Kumasi, Ghana. Am. J. Trop. Med. Hyg. 2010, 82:28-34.
32. Bourguinat C., et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis. 2007, 1:e72.
33. Blackhall W.J., et al. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol. Biochem. Parasitol. 1998, 95:193-201.
34. Njue A.I., Prichard R.K. Genetic variability of glutamate-gated chloride channel genes in ivermectin-susceptible and -resistant strains of Cooperia oncophora. Parasitology 2004, 129:741-751.
35. Geerts S., Gryseels B. Anthelmintic resistance in human helminths: a review. Trop. Med. Int. Health 2001, 6:915-921.
36. Kane N.S., et al. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:13949-13954.
37. Pu X., et al. Characterisation of abamectin resistance in a field-evolved multiresistant population of Plutella xylostella. Pest Manag. Sci. 2009, 66:371-378.
38. Read A.F., et al. How to make evolution-proof insecticides for malaria control. PLoS Biol. 2009, 7:e1000058.
39. Bogh C., et al. Zooprophylaxis, artefact or reality? A paired-cohort study of the effect of passive zooprophylaxis on malaria in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:593-596.
40. Boyce W.M., et al. Use of ivermectin implants for the treatment of psoroptic scabies in free-ranging bighorn sheep. J. Zoo Wildl. Med. 1992, 23:211-213.
41. Harder A. Chemotherapeutic approaches to nematodes: current knowledge and outlook. Parasitol. Res. 2002, 88:272-277.
42. Raymond-Delpech V., et al. Ion channels: molecular targets of neuroactive insecticides. Invert. Neurosci. 2005, 5:119-133.
43. Buckingham S.D., et al. Insect GABA receptors: splicing, editing, and targeting by antiparasitics and insecticides. Mol. Pharmacol. 2005, 68:942-951.
44. Jones A.K., Sattelle D.B. The cys-loop ligand-gated ion channel superfamily of the honeybee, Apis mellifera. Invert. Neurosci. 2006, 6:123-132.
45. Jones A.K., et al. The nicotinic acetylcholine receptor gene family of the malaria mosquito, Anopheles gambiae. Genomics 2005, 85:176-187.
46. Lee D., et al. GABA receptors containing Rdl subunits mediate fast inhibitory synaptic transmission in Drosophila neurons. J. Neurosci. 2003, 23:4625-4634.
47. Gisselmann G., et al. Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric GABA-gated cation channels. Br. J. Pharmacol. 2004, 142:409-413.
48. Bloomquist J.R. Chloride channels as tools for developing selective insecticides. Arch. Insect Biochem. Physiol. 2003, 54:145-156.
49. Schnizler K., et al. A novel chloride channel in Drosophila melanogaster is inhibited by protons. J. Biol. Chem. 2005, 280:16254-16262.
50. Mounsey K., et al. Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabei. Invert. Neurosci. 2007, 7:149-156.
51. Zheng Y., et al. Identification of two novel Drosophila melanogaster histamine-gated chloride channel subunits expressed in the eye. J. Biol. Chem. 2002, 277:2000-2005.
52. Ludmerer S.W., et al. Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both gamma-aminobutyric acid-gated Rdl and glutamate-gated GluCl alpha chloride channel subunits. Biochemistry 2002, 41:6548-6560.
53. Jones A.K., et al. Splice-variant- and stage-specific RNA editing of the Drosophila GABA receptor modulates agonist potency. J. Neurosci. 2009, 29:4287-4292.
54. Shan Q., et al. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 2001, 276:12556-12564.
55. Lespine A., et al. Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs. Curr. Drug Metab. 2009, 10:272-288.
56. Dobson S.L., et al. The effect of Wolbachia-induced cytoplasmic incompatibility on host population size in natural and manipulated systems. Proc. Biol. Sci. 2002, 269:437-445.
57. Smith T., et al. Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop. 1993, 54:55-72.